Cell-Free DNA in Plasma Reveals Genomic Similarity Between Biliary Tract Inflammatory Lesion and Biliary Tract Cancer

Overview

Journal Phenomics

Publisher Springer

Date 2024 Nov 25

PMID 39583313

Authors

Ruimei Liu

Yueqiang Song

Rulin Hua

Shariq Ahmed

Yunxiao Xie

Cong Lai

Jialu Xu

Fuyuan Li

Ying Li

Zhiguang Li

Yinping Wang

Dekang Lv

Qiwei Li

Affiliations

Soon will be listed here.

Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s43657-024-00160-2.

References

Banales J, Cardinale V, Carpino G, Marzioni M, Andersen J, Invernizzi P . Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016; 13(5):261-80. DOI: 10.1038/nrgastro.2016.51. View

Salvi S, Gurioli G, De Giorgi U, Conteduca V, Tedaldi G, Calistri D . Cell-free DNA as a diagnostic marker for cancer: current insights. Onco Targets Ther. 2016; 9:6549-6559. PMC: 5087772. DOI: 10.2147/OTT.S100901. View

. Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2022. Nucleic Acids Res. 2021; 50(D1):D27-D38. PMC: 8728233. DOI: 10.1093/nar/gkab951. View

Berchuck J, Facchinetti F, DiToro D, Baiev I, Majeed U, Reyes S . The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer. Ann Oncol. 2022; 33(12):1269-1283. DOI: 10.1016/j.annonc.2022.09.150. View

Takeshima H, Ushijima T . Accumulation of genetic and epigenetic alterations in normal cells and cancer risk. NPJ Precis Oncol. 2019; 3:7. PMC: 6403339. DOI: 10.1038/s41698-019-0079-0. View

Corcoran R, Chabner B . Application of Cell-free DNA Analysis to Cancer Treatment. N Engl J Med. 2018; 379(18):1754-1765. DOI: 10.1056/NEJMra1706174. View

Lamarca A, Kapacee Z, Breeze M, Bell C, Belcher D, Staiger H . Molecular Profiling in Daily Clinical Practice: Practicalities in Advanced Cholangiocarcinoma and Other Biliary Tract Cancers. J Clin Med. 2020; 9(9). PMC: 7563385. DOI: 10.3390/jcm9092854. View

Kang M, Lim J, Han S, Park H, Kim S, Lee W . Distinct prognosis of biliary tract cancer according to tumor location, stage, and treatment: a population-based study. Sci Rep. 2022; 12(1):10206. PMC: 9205970. DOI: 10.1038/s41598-022-13605-3. View

Chen T, Chen X, Zhang S, Zhu J, Tang B, Wang A . The Genome Sequence Archive Family: Toward Explosive Data Growth and Diverse Data Types. Genomics Proteomics Bioinformatics. 2021; 19(4):578-583. PMC: 9039563. DOI: 10.1016/j.gpb.2021.08.001. View

10.

Xu C, Ranjbar M, Wu Z, Dicarlo J, Wang Y . Detecting very low allele fraction variants using targeted DNA sequencing and a novel molecular barcode-aware variant caller. BMC Genomics. 2017; 18(1):5. PMC: 5209917. DOI: 10.1186/s12864-016-3425-4. View

11.

Lowery M, Ptashkin R, Jordan E, Berger M, Zehir A, Capanu M . Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention. Clin Cancer Res. 2018; 24(17):4154-4161. PMC: 6642361. DOI: 10.1158/1078-0432.CCR-18-0078. View

12.

Cingolani P . Variant Annotation and Functional Prediction: SnpEff. Methods Mol Biol. 2022; 2493:289-314. DOI: 10.1007/978-1-0716-2293-3_19. View

13.

Robles A, Traverso G, Zhang M, Roberts N, Khan M, Joseph C . Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers. Gastroenterology. 2016; 150(4):931-43. PMC: 5270616. DOI: 10.1053/j.gastro.2015.12.036. View

14.

Roy S, Glaser S, Chakraborty S . Inflammation and Progression of Cholangiocarcinoma: Role of Angiogenic and Lymphangiogenic Mechanisms. Front Med (Lausanne). 2020; 6:293. PMC: 6930194. DOI: 10.3389/fmed.2019.00293. View

15.

Nakamura H, Arai Y, Totoki Y, Shirota T, Elzawahry A, Kato M . Genomic spectra of biliary tract cancer. Nat Genet. 2015; 47(9):1003-10. DOI: 10.1038/ng.3375. View

16.

Hsing A, Sakoda L, Rashid A, Andreotti G, Chen J, Wang B . Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. Cancer Res. 2008; 68(15):6442-52. PMC: 2860726. DOI: 10.1158/0008-5472.CAN-08-0444. View

17.

Xu C, Gu X, Padmanabhan R, Wu Z, Peng Q, Dicarlo J . smCounter2: an accurate low-frequency variant caller for targeted sequencing data with unique molecular identifiers. Bioinformatics. 2018; 35(8):1299-1309. PMC: 6477992. DOI: 10.1093/bioinformatics/bty790. View

18.

Banales J, Marin J, Lamarca A, Rodrigues P, Khan S, Roberts L . Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020; 17(9):557-588. PMC: 7447603. DOI: 10.1038/s41575-020-0310-z. View

19.

Gou Q, Zhang C, Sun Z, Wu L, Chen Y, Mo Z . Cell-free DNA from bile outperformed plasma as a potential alternative to tissue biopsy in biliary tract cancer. ESMO Open. 2021; 6(6):100275. PMC: 8517551. DOI: 10.1016/j.esmoop.2021.100275. View

20.

Xiao X, Zhou J, Fang M, Ji J, Huang C, Du F . Quantitative detections of TP53 gene mutations improve the diagnosis and prognostic prediction of biliary tract cancers using droplet digital PCR. J Clin Lab Anal. 2021; 36(1):e24103. PMC: 8761443. DOI: 10.1002/jcla.24103. View